國泰(00293.HK)擬斥27.1億美元購6架A350F貨機
國泰(00293.HK公布,其全資擁有公司CPAS向空中巴士公司購買6架空中巴士A350F型貨機飛機;及CPAS取得購買額外20架空中巴士A350F型飛機的權利。
國泰指,空中巴士飛機的飛機基本價格約為27.1億美元,折合約為211.38億港元,並將分八期以現金支付,每架飛機的首七期款額將於該飛機付運前支付,佔代價相當大部分的餘款將於該飛機付運時支付。公司預期於2029年年底前付運。
交易的全部或部分資金擬通過售後回租安排及/或融資租賃,以及商業銀行貸款及/或由公司業務營運產生的現金提供。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.